Clinical Trial Update: Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating irinotecan in combination with cisplatin for patients undergoing surgery for locally advanced gastric or gastroesophageal junct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Gastric Adenocarcinoma, Stage II Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-07-06